Key result
Shared risk factors and genetic defects shape variable atherosclerotic phenotypes in familial hypercholesterolemia.
Answers are grounded in this paper and cite their sources.
Heterozygous familial hypercholesterolaemia is among the most common inherited dominant disorders, and is characterized by severely elevated LDL-cholesterol levels and premature cardiovascular disease. Although the cause of familial hypercholesterolaemia is monogenic, there is a substantial variation in the onset and severity of atherosclerotic disease symptoms. Additional atherogenic risk factors of environmental, metabolic and genetic origin, in conjunction with the LDL receptor defect, are presumed to influence the clinical phenotype in familial hypercholesterolaemia. The present review discusses recent developments in this field.
No takes yet. Share an insight, caveat, or question.
Jansen et al. (2002) conducted a review in Heterozygous familial hypercholesterolaemia. Environmental, metabolic, and genetic risk factors alongside LDL receptor defect was evaluated on Onset and severity of atherosclerotic disease symptoms. Environmental, metabolic, and genetic risk factors in conjunction with LDL receptor defects are presumed to influence atherosclerotic phenotype variability in familial hypercholesterolaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: